摘要
目的探讨经皮~(125)Ⅰ粒子植入术后肿瘤针道种植转移的临床观察。方法回顾性分析2007年1月至2017年1月接受CT导引下经皮~(125)Ⅰ粒子植入治疗1 260例患者临床资料。结果 6例(0.48%,6/1 260)患者发生针道种植转移,其中肝癌4例,肺癌2例,患者平均使用穿刺针(9.5±3.8)根;平均植入粒子数(80.8±42.9)颗;发现针道种植转移的平均时间为(113.7±34.3)d;种植瘤平均体积8.09 cm3;病理结果示3例低分化,2例中低分化,1例为高分化。针对转移灶治疗方式:1例放弃治疗,3例行~(125)Ⅰ粒子植入治疗,1例行外科切除,1例行常规放射治疗,治疗的5例患者均取得良好的肿瘤局部控制效果,无患者因针道转移病灶导致死亡。结论经皮~(125)Ⅰ粒子植入治疗后可能发生肿瘤针道种植转移,但发生率低,经过积极治疗后,不会成为患者的致死因素。
Objective To discuss the clinical features of neoplasm needle track implantation metastasis after125 I seed implantation. Methods The clinical data of 1260 patients, who received CT-guided percutaneous125 I seeds implantation during the period from January 2007 to January 2010 at authors' hospital, were retrospectively analyzed. Results A total of 6 patients(0.48%,6/1260) developed neoplastic needle tract seeding, including 4 patients with liver cancer and 2 patients with lung cancer. The average number of used puncture needle was(9.5±3.8) needles, the average number of implanted125 I seed was(80.8±42.9) seeds. The mean time to discover needle track implantation metastasis was(113.7 ±34.3) d, and the mean volume of implanted tumor was 8.09 cm3. Pathological examination showed that poorly-differentiated cancer was seen in 3 patients, mid-poorly-differentiated cancer in 2 patients, and well-differentiated cancer in one patient. One patient gave up treatment, 3 patients received CT-guided percutaneous125 I seeds implantation, one patient underwent surgical resection, and one patient received routine radiotherapy.Satisfactory local control effect of tumor was obtained in all 5 patients who received treatments. No death due to neoplasm needle track implantation metastasis occurred. Conclusion Neoplasm needle track implantation metastasis may occur after percutaneous125 I seeds implantation therapy, although the incidence is extremely low. Usually, neoplasm needle track implantation metastasis will not become the lethal factor when active treatment is properly adopted.
引文
[1]王俊杰.精准时代的放射性粒子植入治疗[J].中华核医学与分子影像杂志,2018,38:1-3.
[2]孔国强,高社干,任婧,等.腹腔热化疗联合静脉化疗治疗恶性腹水的临床观察[J].实用中西医结合临床,2018,18:107-108.
[3]Van Houdt WJ,Schrijver AM,Cohen-Hallaleh RB,et al.Needle tract seeding following core biopsies in retroperitoneal sarcoma[J].Eur J Surg Oncol,2017,43:1740-1745.
[4]Sumiyoshi T,Shima Y,Nishiuchi R,et al.Needle tract implantation of hepatoblastoma after percutaneous needle biopsy:report of a case[J].Surg Today,2014,44:1138-1141.
[5]王娟,公维宏,范会革,等.放射性粒子植入术针道医源性肿瘤种植转移的临床观察[J].中华放射肿瘤学杂志,2007,16:253-254.
[6]Ochsner A,Debakey M.Significance of metastasis in primary carcinomas of the lung[J].J Thorac Surg,1942,11:357-387.
[7]Ryd W,Hagmar B,Eriksson O.Local tumour cell seeding by fine-needle aspiration biopsy.A semiquantitative study[J].Acta Pathol Microbiol Immunol Scand A,1983,91:17-21.
[8]Chang S,Kim SH,Lim HK,et al.Needle tract implantation after percutaneous interventional procedures in hepatocellular carcinomas;Lessons learned from a 10-year experience[J].Korean J Radiol,2008,9:268-274.
[9]Chang S,Kim SH,Lim HK,et al.Needle tract implantation after sonographically guided percutaneous biopsy of hepatocellular carcinoma:evaluation of doubling time,frequency,and features on CT[J].AJR Am J Roentgenol,2005,185:400-405.
[10]Kosugi C,Furuse J,Ishii H,et al.Needle tract implantation of hepatocellular carcinoma and pancreatic carcinoma after ultrasound-guided percutaneous puncture:clinical and pathologic characteristics and the treatment of needle tract implantation[J].World J Surg,2004,28:29-32.
[11]王娟,隋爱霞,赵静,等.CT引导下经胃入路125I粒子治疗腹膜后转移癌10例[J].介入放射学杂志,2015,24:698-701.